Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine
Julia M. L. Brotherton A B I , Christopher K. Fairley C D , Suzanne M. Garland E F G H , Dorota Gertig A and Marion Saville AA Victorian Cytology Service, PO Box 310, East Melbourne, Vic. 8002, Australia.
B National Centre for Immunisation Research and Surveillance, The Children’s Hospital at Westmead, Discipline of Paediatrics and Child Health, School of Public Health, University of Sydney, Sydney, NSW 2006, Australia.
C Melbourne Sexual Health Centre, 580 Swanston Street, Carlton, Vic. 3053, Australia.
D School of Population Health, University of Melbourne, Carlton, Vic. 3053, Australia.
E Clinical Microbiology and Infectious Diseases, Royal Women’s Hospital, Melbourne, Vic. 3052, Australia.
F Department of Clinical Microbiology, Royal Children’s Hospital, Melbourne, Vic. 3052, Australia.
G Faculty of Medicine, Dentistry and Health, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Vic. 3053, Australia.
H Murdoch Children’s Research Institute, University of Melbourne, Melbourne, Vic. 3052, Australia.
I Corresponding author. Email: jbrother@vcs.org.au
Sexual Health 7(3) 397-398 https://doi.org/10.1071/SH10075
Submitted: 21 June 2010 Accepted: 24 June 2010 Published: 19 August 2010
[1] Tota J, Mahmud SM, Ferenczy A, Coutlée F, Franco EL. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era. Sex Health 2010; 7 376–82.
| Crossref | GoogleScholarGoogle Scholar |
[2] Gertig DM, Brotherton JML, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2010;
| Crossref | GoogleScholarGoogle Scholar |
[3] Beutels P, Jit M. A brief history of economic evaluation for human papillomavirus vaccination policy. Sex Health 2010; 7 352–8.
| Crossref | GoogleScholarGoogle Scholar |
[4] Cooper Robbins SC, Bernard D, McCaffery K, Skinner SR. “It’s a logistical nightmare!”: recommendations for optimising human papillomavirus school-based vaccination experiences. Sex Health 2010; 7 271–8.
| Crossref | GoogleScholarGoogle Scholar |
[5] Brotherton JML, Leask J, Jackson C, McCaffery K, Trevena LJ. National survey of the general practitioner’s experience of delivering the National Human Papillomavirus Vaccination Program. Sex Health 2010; 7 291–8.
| Crossref | GoogleScholarGoogle Scholar |
[6] Gold MS, Buttery J, McIntyre P. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance. Sex Health 2010; 7 320–4.
| Crossref | GoogleScholarGoogle Scholar |
[7] Fairley CK, Donovan B. What can surveillance of genital warts tell us? Sex Health 2010; 7 325–7.
| Crossref | GoogleScholarGoogle Scholar |
[8] Canfell K. Models of cervical screening in the era of human papillomavirus vaccination. Sex Health 2010; 7 359–67.
| Crossref | GoogleScholarGoogle Scholar |
[9] Regan DG, Philip DJ, Waters EK. Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective. Sex Health 2010; 7 368–75.
| Crossref | GoogleScholarGoogle Scholar |
[10] Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health 2010; 7 244–52.
| Crossref | GoogleScholarGoogle Scholar |
[11] Simatherai D, Bradshaw CS, Fairley CK, Bush M, Heley S, Chen MY. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009; 85 148–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[12] Nghi NQ, LaMontagne DS, Bingham A, Rafiq M, Mai LTP, Lien NTP, et al. Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health 2010; 7 262–70.
| Crossref | GoogleScholarGoogle Scholar |
[13] McIntyre P. Commentary on opinion pieces are Australian human papillomavirus vaccine policy. Sex Health 2010; 7 242–3.
| Crossref | GoogleScholarGoogle Scholar |
